Operative Outcomes Following Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy (Sbrt) for Borderline Resectable and Locally Advanced Pancreatic Cancer

HPB - United Kingdom
doi 10.1016/j.hpb.2019.03.072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study

International Journal of Contemporary Medical Research [IJCMR]
2019English

Serum Protein Expression and Associations With Conversion to Resectable Status Following Chemotherapy and Stereotactic Body Radiation Therapy in Locally Advanced Pancreatic Adenocarcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Outcomes With FOLFIRINOX for Borderline Resectable and Locally Unresectable Pancreatic Cancer

Journal of Surgical Oncology
MedicineSurgeryOncology
2013English

Erratum To: Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival

Annals of Surgical Oncology
OncologySurgery
2014English

Dosimetric Constraints in Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: Capacity for Dose Escalation

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

Oncologist
Cancer ResearchMedicineOncology
2019English

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Clinical Medicine
2020English

Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advance Pancreatic Cancer (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short- And Long-Term Outcomes

HPB
HepatologyGastroenterology
2019English

A Pilot Study- Neoadjuvant Chemotherapy With Gemcitabine and S1 in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Journal of Carcinogenesis & Mutagenesis
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy